122 related articles for article (PubMed ID: 33721738)
21. Collaborative care for panic disorder, generalised anxiety disorder and social phobia in general practice: study protocol for three cluster-randomised, superiority trials.
Curth NK; Brinck-Claussen UØ; Davidsen AS; Lau ME; Lundsteen M; Mikkelsen JH; Csillag C; Hjorthøj C; Nordentoft M; Eplov LF
Trials; 2017 Aug; 18(1):382. PubMed ID: 28814317
[TBL] [Abstract][Full Text] [Related]
22. Pattern of structural brain changes in social anxiety disorder after cognitive behavioral group therapy: a longitudinal multimodal MRI study.
Steiger VR; Brühl AB; Weidt S; Delsignore A; Rufer M; Jäncke L; Herwig U; Hänggi J
Mol Psychiatry; 2017 Aug; 22(8):1164-1171. PubMed ID: 27922605
[TBL] [Abstract][Full Text] [Related]
23. Reductions in body weight and insulin resistance are not associated with changes in grey matter volume or cortical thickness during the PREVIEW study.
Drummen M; Heinecke A; Dorenbos E; Vreugdenhil A; Raben A; Westerterp-Plantenga MS; Adam TC
J Neurol Sci; 2019 Aug; 403():106-111. PubMed ID: 31255969
[TBL] [Abstract][Full Text] [Related]
24. Hypochondriasis Differs From Panic Disorder and Social Phobia: Specific Processes Identified Within Patient Groups.
Höfling V; Weck F
J Nerv Ment Dis; 2017 Mar; 205(3):227-233. PubMed ID: 27805984
[TBL] [Abstract][Full Text] [Related]
25. A morphometric signature of depressive symptoms in unmedicated patients with mood disorders.
Wise T; Marwood L; Perkins AM; Herane-Vives A; Williams SCR; Young AH; Cleare AJ; Arnone D
Acta Psychiatr Scand; 2018 Jul; 138(1):73-82. PubMed ID: 29682732
[TBL] [Abstract][Full Text] [Related]
26. Regional grey matter volume and concentration in at-risk adolescents: Untangling associations with callous-unemotional traits and conduct disorder symptoms.
Cohn MD; Viding E; McCrory E; Pape L; van den Brink W; Doreleijers TA; Veltman DJ; Popma A
Psychiatry Res Neuroimaging; 2016 Aug; 254():180-7. PubMed ID: 27479922
[TBL] [Abstract][Full Text] [Related]
27. Regional gray matter abnormalities in panic disorder: a voxel-based morphometry study.
Uchida RR; Del-Ben CM; Busatto GF; Duran FL; Guimarães FS; Crippa JA; Araújo D; Santos AC; Graeff FG
Psychiatry Res; 2008 May; 163(1):21-9. PubMed ID: 18417322
[TBL] [Abstract][Full Text] [Related]
28. Regional brain volume in depression and anxiety disorders.
van Tol MJ; van der Wee NJ; van den Heuvel OA; Nielen MM; Demenescu LR; Aleman A; Renken R; van Buchem MA; Zitman FG; Veltman DJ
Arch Gen Psychiatry; 2010 Oct; 67(10):1002-11. PubMed ID: 20921116
[TBL] [Abstract][Full Text] [Related]
29. Structural and metabolic cerebral alterations between elderly bipolar disorder and behavioural variant frontotemporal dementia: A combined MRI-PET study.
Delvecchio G; Mandolini GM; Arighi A; Prunas C; Mauri CM; Pietroboni AM; Marotta G; Cinnante CM; Triulzi FM; Galimberti D; Scarpini E; Altamura AC; Brambilla P
Aust N Z J Psychiatry; 2019 May; 53(5):413-423. PubMed ID: 30545239
[TBL] [Abstract][Full Text] [Related]
30. A subtle grey-matter increase in first-episode, drug-naive major depressive disorder with panic disorder after 6 weeks' duloxetine therapy.
Lai CH; Hsu YY
Int J Neuropsychopharmacol; 2011 Mar; 14(2):225-35. PubMed ID: 20663271
[TBL] [Abstract][Full Text] [Related]
31. Gray Matter Abnormalities in Non-comorbid Medication-naive Patients with Major Depressive Disorder or Social Anxiety Disorder.
Zhao Y; Chen L; Zhang W; Xiao Y; Shah C; Zhu H; Yuan M; Sun H; Yue Q; Jia Z; Zhang W; Kuang W; Gong Q; Lui S
EBioMedicine; 2017 Jul; 21():228-235. PubMed ID: 28633986
[TBL] [Abstract][Full Text] [Related]
32. Increased MRI-based cortical grey/white-matter contrast in sensory and motor regions in schizophrenia and bipolar disorder.
Jørgensen KN; Nerland S; Norbom LB; Doan NT; Nesvåg R; Mørch-Johnsen L; Haukvik UK; Melle I; Andreassen OA; Westlye LT; Agartz I
Psychol Med; 2016 Jul; 46(9):1971-85. PubMed ID: 27049014
[TBL] [Abstract][Full Text] [Related]
33. Staging of cortical and deep grey matter functional connectivity changes in multiple sclerosis.
Meijer KA; Eijlers AJC; Geurts JJG; Schoonheim MM
J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):205-210. PubMed ID: 28986469
[TBL] [Abstract][Full Text] [Related]
34. SPECT [I-123]iomazenil measurement of the benzodiazepine receptor in panic disorder.
Bremner JD; Innis RB; White T; Fujita M; Silbersweig D; Goddard AW; Staib L; Stern E; Cappiello A; Woods S; Baldwin R; Charney DS
Biol Psychiatry; 2000 Jan; 47(2):96-106. PubMed ID: 10664825
[TBL] [Abstract][Full Text] [Related]
35. Decreased Regional Grey Matter Volume in Women with Chronic Whiplash-Associated Disorders: Relationships with Cognitive Deficits and Disturbed Pain Processing.
Coppieters I; De Pauw R; Caeyenberghs K; Danneels L; Kregel J; Pattyn A; Meeus M; Cagnie B
Pain Physician; 2017 Nov; 20(7):E1025-E1051. PubMed ID: 29149149
[TBL] [Abstract][Full Text] [Related]
36. Sexually dimorphic gray matter volume reduction in patients with panic disorder.
Asami T; Yamasue H; Hayano F; Nakamura M; Uehara K; Otsuka T; Roppongi T; Nihashi N; Inoue T; Hirayasu Y
Psychiatry Res; 2009 Aug; 173(2):128-34. PubMed ID: 19560907
[TBL] [Abstract][Full Text] [Related]
37. Nondermatomal somatosensory deficits in chronic pain are associated with cerebral grey matter changes.
Riederer F; Landmann G; Gantenbein AR; Stockinger L; Egloff N; Sprott H; Schleinzer W; Pirrotta R; Dumat W; Luechinger R; Baumgartner C; Kollias S; Sándor PS
World J Biol Psychiatry; 2017 Apr; 18(3):227-238. PubMed ID: 26492569
[TBL] [Abstract][Full Text] [Related]
38. Altered grey matter volume and cortical thickness in patients with schizo-obsessive comorbidity.
Wang YM; Zou LQ; Xie WL; Yang ZY; Zhu XZ; Cheung EFC; Sørensen TA; Møller A; Chan RCK
Psychiatry Res Neuroimaging; 2018 Jun; 276():65-72. PubMed ID: 29628272
[TBL] [Abstract][Full Text] [Related]
39. Panic disorder and social phobia: effects of comorbidity on familial transmission.
Fyer AJ; Mannuzza S; Chapman TF; Lipsitz J; Martin LY; Klein DF
Anxiety; 1996; 2(4):173-8. PubMed ID: 9160619
[TBL] [Abstract][Full Text] [Related]
40. Altered cerebral gamma-aminobutyric acid type A-benzodiazepine receptor binding in panic disorder determined by [11C]flumazenil positron emission tomography.
Hasler G; Nugent AC; Carlson PJ; Carson RE; Geraci M; Drevets WC
Arch Gen Psychiatry; 2008 Oct; 65(10):1166-75. PubMed ID: 18838633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
